Biocon Ltd., an innovation-led global biopharmaceuticals company, announced, that its Board has approved the appointment of Peter Bains as the Group CEO, with effect from September 18th, 2023. He will be reporting directly to Biocon Group Chairperson, Kiran Mazumdar-Shaw. Bains has accordingly stepped down from his role on the Biocon Board as an Independent Director with…
Biocon Limited announced the appointment of Peter Bains as Independent Director on the company’s Board, with effect from December 12, 2022. According to the company’s exchange filing, “Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, (‘SEBI Listing Regulations’) and in continuation to our letter dated November 14, 2022, wherein it…